Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)

China flag China · Delayed Price · Currency is CNY
21.41
+0.22 (1.04%)
Mar 10, 2026, 1:45 PM CST
5.52%
Market Cap 11.93B
Revenue (ttm) 3.78B
Net Income (ttm) 799.61M
Shares Out 563.16M
EPS (ttm) 1.40
PE Ratio 15.11
Forward PE 15.26
Dividend 0.90 (4.18%)
Ex-Dividend Date Jun 20, 2025
Volume 3,121,782
Average Volume 6,544,281
Open 21.30
Previous Close 21.19
Day's Range 21.23 - 21.56
52-Week Range 20.30 - 24.94
Beta 0.17
RSI 48.48
Earnings Date Apr 28, 2026

About SHA:600285

Henan Lingrui Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China. It operates through Pharmaceutical and Healthcare Division; and Others segments. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, and tinctures, etc. for various indications, including orthopedic, cardiovascular, cerebrovascular, dermatology, pediatrics, respiratory, and anesthesiology. Its products include Tongluoqutong plasters, Peiyuan... [Read more]

Sector Healthcare
Founded 1992
Employees 2,435
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600285
Full Company Profile

Financial Performance

In 2024, SHA:600285's revenue was 3.50 billion, an increase of 5.72% compared to the previous year's 3.31 billion. Earnings were 722.55 million, an increase of 27.19%.

Financial Statements

News

There is no news available yet.